Linvencorvir
N/A
Report date: 2023/12/29 17:14:37
NME
Base Information
Drug NameLinvencorvir
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[18]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesRoche R&D Center (China) LtdF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A